These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22540524)

  • 1. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial.
    Rafiq S; Johansson PI; Zacho M; Stissing T; Kofoed K; Lilleør NB; Steinbrüchel DA
    Trials; 2012 Apr; 13():48. PubMed ID: 22540524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial.
    Rafiq S; Johansson PI; Kofoed KF; Lund JT; Olsen PS; Bentsen S; Steinbrüchel DA
    Platelets; 2017 Dec; 28(8):786-793. PubMed ID: 28277060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting.
    Gao C; Ren C; Li D; Li L
    Ann Thorac Surg; 2009 Jul; 88(1):59-62. PubMed ID: 19559191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy.
    Kulik A; Chan V; Ruel M
    Expert Opin Drug Saf; 2009 Mar; 8(2):169-82. PubMed ID: 19309245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639].
    Gasparovic H; Petricevic M; Kopjar T; Djuric Z; Svetina L; Biocina B
    Trials; 2012 Aug; 13():148. PubMed ID: 22920307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    Zhao Q; Zhu Y; Xu Z; Cheng Z; Mei J; Chen X; Wang X
    JAMA; 2018 Apr; 319(16):1677-1686. PubMed ID: 29710164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909).
    Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M
    Contemp Clin Trials; 2018 May; 68():45-51. PubMed ID: 29551675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of clopidogrel use post coronary artery bypass surgery on graft patency.
    Ebrahimi R; Bakaeen FG; Uberoi A; Ardehali A; Baltz JH; Hattler B; Almassi GH; Wagner TH; Collins JF; Grover FL; Shroyer AL
    Ann Thorac Surg; 2014 Jan; 97(1):15-21. PubMed ID: 24206971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aspirin and clopidogrel after coronary artery bypass graft surgery.
    de Leon N; Jackevicius CA
    Ann Pharmacother; 2012 May; 46(5):678-87. PubMed ID: 22570427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
    Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
    J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative platelet aggregation predicts perioperative blood loss and rethoracotomy for bleeding in patients receiving dual antiplatelet treatment prior to coronary surgery.
    Plicner D; Mazur P; Hymczak H; Stoliński J; Litwinowicz R; Drwiła R; Undas A
    Thromb Res; 2015 Sep; 136(3):519-25. PubMed ID: 26003782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.
    Mannacio VA; Di Tommaso L; Antignan A; De Amicis V; Vosa C
    Heart; 2012 Dec; 98(23):1710-5. PubMed ID: 22942294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial.
    Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M
    Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulability in relation to coronary artery bypass graft patency and clinical outcome.
    Zacho M; Rafiq S; Kelbæk H; Johansson PI; Nielsen MB; Steinbrüchel DA; Kofoed KF
    Scand Cardiovasc J; 2013 Apr; 47(2):104-8. PubMed ID: 23205579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Earlier application of loading doses of aspirin and clopidogrel decreases rate of recurrent cardiovascular ischemic events for patients undergoing percutaneous coronary intervention.
    Tang FK; Lin LJ; Hua N; Lu H; Qi Z; Tang XZ
    Chin Med J (Engl); 2012 Feb; 125(4):631-8. PubMed ID: 22490487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel.
    Nielsen AB; Bochsen L; Steinbrüchel DA
    Scand Cardiovasc J; 2007 Oct; 41(5):325-30. PubMed ID: 17852789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow-up of the Clopidogrel After Surgery for Coronary Artery Disease (CASCADE) trial.
    Hage A; Voisine P; Erthal F; Larose É; Glineur D; Chow B; Tremblay H; Fortier J; Ko G; Une D; Farkouh M; Mesana TG; LeMay M; Kulik A; Ruel M
    J Thorac Cardiovasc Surg; 2018 Jan; 155(1):212-222.e2. PubMed ID: 28734623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.